Tulsi Ram Bhattarai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tulsi Ram Bhattarai has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aakash Mishra
Kathmandu Medical College Teaching Hospital Kathmandu Nepal
3 shared publications - Shekhar Poudel
Fellow Transplant Hepatology, Centre for Liver and Biliary Sciences, Max Super Specialty Hospital, Saket, New Delhi, India
3 shared publications - Sujan Chandra Poudel
Kathmandu University
2 shared publications - Aman Mishra
Tribhuvan University Institute of Medicine Maharajgunj Medical Campus Kathmandu, Bagmati Province, Nepal
1 shared publication - Prinsa Shrestha
Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal
1 shared publication
Latest Publications
- Open Access
- 1 July 2022
- Published by Nepal Journals Online (JOL) in Journal of Kathmandu Medical College
- p. 100-104
Clinical profile of COVID-19 patients admitted in a tertiary care hospital of Nepal: A descriptive cross-sectional study
Background: Coronavirus disease 2019 (COVID-19) causes mild to severe respiratory illness and is associated with ICU admission and mortality. Since data regarding clinical profile of COVID-19 patients in Nepal is still lacking, it is important to study clinical behaviour of COVID-19 in Nepal. In this study the demographic profile, clinical features, lab parameters, and outcomes in hospitalised COVID-19 patients in a tertiary care hospital are reported. Objective: To assess the clinical profile in terms of clinical symptoms, laboratory parameters, and outcome of COVID-19 admitted patients in a tertiary care hospital. Methods: This is a descriptive cross-sectional study conducted at KMCTH, from June 1, 2021 to July 31, 2021 after taking ethical clearance from institutional review committee. All patients infected with COVID-19 admitted in this hospital, from June 1, 2021 to July 31, 2021 were included by convenience sampling. Data were collected, and entry and analysis were done in Microsoft Excel Sheet 2007. Results: During the study period, 245 COVID-19 patients were admitted and were included in the study. The median age of the patients was 55 years, the mean age was 55 ± 17 years, and 139 (56.74%) were male. The common presenting complaints were cough in 180 (73.47%) followed by fever in 176 (71.84%) patients. Most common comorbidity found was hypertension in 89 (36.33%), followed by diabetes in 50 (20.44%). Conclusion: In this single-centred study, the characteristic features included presence of comorbidities, higher level of inflammatory markers, and high mortality rate in severe to critical hospitalised COVID-19 patients.
- 1 July 2022
- Published by Nepal Journals Online (JOL) in Journal of Kathmandu Medical College
- p. 100-104
Open AccessClinical profile of COVID-19 patients admitted in a tertiary care hospital of Nepal: A descriptive cross-sectional study
Background: Coronavirus disease 2019 (COVID-19) causes mild to severe respiratory illness and is associated with ICU admission and mortality. Since data regarding clinical profile of COVID-19 patients in Nepal is still lacking, it is important to study clinical behaviour of COVID-19 in Nepal. In this study the demographic profile, clinical features, lab parameters, and outcomes in hospitalised COVID-19 patients in a tertiary care hospital are reported. Objective: To assess the clinical profile in terms of clinical symptoms, laboratory parameters, and outcome of COVID-19 admitted patients in a tertiary care hospital. Methods: This is a descriptive cross-sectional study conducted at KMCTH, from June 1, 2021 to July 31, 2021 after taking ethical clearance from institutional review committee. All patients infected with COVID-19 admitted in this hospital, from June 1, 2021 to July 31, 2021 were included by convenience sampling. Data were collected, and entry and analysis were done in Microsoft Excel Sheet 2007. Results: During the study period, 245 COVID-19 patients were admitted and were included in the study. The median age of the patients was 55 years, the mean age was 55 ± 17 years, and 139 (56.74%) were male. The common presenting complaints were cough in 180 (73.47%) followed by fever in 176 (71.84%) patients. Most common comorbidity found was hypertension in 89 (36.33%), followed by diabetes in 50 (20.44%). Conclusion: In this single-centred study, the characteristic features included presence of comorbidities, higher level of inflammatory markers, and high mortality rate in severe to critical hospitalised COVID-19 patients.
- Open Access
- 27 June 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (6) , e6005
Eosinophilic gastritis without peripheral eosinophilia and atopy: A case report
Eosinophilic gastritis (EG) is characterized by eosinophilic infiltration of any gastric layers. We report a 65‐year‐female presenting with abdominal pain and vomiting for two months. Chronic gastritis not responding to empirical treatment interrogated further investigations. In the absence of atopy and peripheral eosinophilia, successful treatment of a large solitary antral ulcer with steroids upheld the diagnosis of EG.
- 27 June 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (6) , e6005
Open AccessEosinophilic gastritis without peripheral eosinophilia and atopy: A case report
Eosinophilic gastritis (EG) is characterized by eosinophilic infiltration of any gastric layers. We report a 65‐year‐female presenting with abdominal pain and vomiting for two months. Chronic gastritis not responding to empirical treatment interrogated further investigations. In the absence of atopy and peripheral eosinophilia, successful treatment of a large solitary antral ulcer with steroids upheld the diagnosis of EG.
- 6 June 2022
- Published by Nepal Journals Online (JOL) in Journal of Kathmandu Medical College
- p. 68-73
Gastrointestinal manifestations and outcomes of hospitalised patients with COVID-19 disease
Background: COVID-19 infection usually presents with respiratory symptoms. Many hospitalised patients of COVID-19 present with gastrointestinal symptoms which can alter the clinical outcomes of patients. Objectives: To characterise the gastrointestinal manifestations of COVID-19 patients requiring hospitalisation and their correlation with disease severity and clinical outcomes. Methods: This was a single centre prospective, observational, cohort study done at Kathmandu Medical College, a tertiary health care centre after ethical clearance. All consecutive hospitalised patients with COVID-19 disease admitted during May and June 2021 were included in the study after ethical clearance. Diagnosis of COVID-19 infection was done by RT-PCR. Gastrointestinal symptoms of abdominal pain, aguesia, nausea/vomiting, and diarrhoea were recorded on hospital admission and outcomes accessed at discharge. Data were analysed using SPSS v.24. Results: A total of 196 consecutive adult patients with COVID-19 infection were included in study. Gastrointestinal symptoms were recorded in 48 (24.5%) patients. The most frequent symptom was nausea/vomiting (23, 11.7%) followed by aguesia (19, 9.7%), diarrhoea (14, 7.1%), and abdominal pain (8, 4.1%). There was no significant association between duration of hospital stay and presence of gastrointestinal symptoms (10.15 vs 10.95 days; p = 0.481). No significance was seen on association of gastrointestinal symptoms with ICU admission and mortality but requirement of mechanical ventilation was significantly higher in patients without symptoms (10.4 vs 23.6%; p = 0.048). Conclusion: Significant proportion of patients with COVID-19 infection can have gastrointestinal manifestations. Presences of these symptoms do not have any association with the final clinical outcome of the patient.
- 6 June 2022
- Published by Nepal Journals Online (JOL) in Journal of Kathmandu Medical College
- p. 68-73
Gastrointestinal manifestations and outcomes of hospitalised patients with COVID-19 disease
Background: COVID-19 infection usually presents with respiratory symptoms. Many hospitalised patients of COVID-19 present with gastrointestinal symptoms which can alter the clinical outcomes of patients. Objectives: To characterise the gastrointestinal manifestations of COVID-19 patients requiring hospitalisation and their correlation with disease severity and clinical outcomes. Methods: This was a single centre prospective, observational, cohort study done at Kathmandu Medical College, a tertiary health care centre after ethical clearance. All consecutive hospitalised patients with COVID-19 disease admitted during May and June 2021 were included in the study after ethical clearance. Diagnosis of COVID-19 infection was done by RT-PCR. Gastrointestinal symptoms of abdominal pain, aguesia, nausea/vomiting, and diarrhoea were recorded on hospital admission and outcomes accessed at discharge. Data were analysed using SPSS v.24. Results: A total of 196 consecutive adult patients with COVID-19 infection were included in study. Gastrointestinal symptoms were recorded in 48 (24.5%) patients. The most frequent symptom was nausea/vomiting (23, 11.7%) followed by aguesia (19, 9.7%), diarrhoea (14, 7.1%), and abdominal pain (8, 4.1%). There was no significant association between duration of hospital stay and presence of gastrointestinal symptoms (10.15 vs 10.95 days; p = 0.481). No significance was seen on association of gastrointestinal symptoms with ICU admission and mortality but requirement of mechanical ventilation was significantly higher in patients without symptoms (10.4 vs 23.6%; p = 0.048). Conclusion: Significant proportion of patients with COVID-19 infection can have gastrointestinal manifestations. Presences of these symptoms do not have any association with the final clinical outcome of the patient.